---
document_datetime: 2023-12-04 16:04:19
document_pages: 11
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/semglee-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: semglee-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 6.8854651
conversion_datetime: 2025-12-17 08:49:18.020103
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Semglee

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IAIN/0047            | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 30/11/2023                          |                                             | Annex II and PL                  |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| T/0046             | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                    | 03/08/2023   | 25/08/2023   | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                       |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0045          | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                     | 12/06/2023   | n/a          |                                  |                                                                                                                                                                                                                                                                       |
| N/0044             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                       | 17/05/2023   |              | Labelling and PL                 |                                                                                                                                                                                                                                                                       |
| IB/0043/G          | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) | 10/03/2023   | n/a          |                                  |                                                                                                                                                                                                                                                                       |
| R/0040             | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                | 15/12/2022   | 15/02/2023   | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Semglee in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| PSUSA/1751/ 202204 | Periodic Safety Update EU Single assessment - insulin glargine                                                                                                                                                                                                                                                                                                                                         | 01/12/2022   | n/a          |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                     |
| IA/0042            | B.I.a.4.b - Change to in-process tests or limits                                                                                                                                                                                                                                                                                                                                                       | 29/11/2022   | n/a          |                                  |                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

|           | applied during the manufacture of the AS - Addition of a new in-process test and limits                                                                                                                                                                                                                                                                                                                                                                                        |            |     |                   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------------|
| IB/0039/G | This was an application for a group of variations. B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New storage site of MCB and/or WCB B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New storage site of MCB and/or WCB                                                                                                                                             | 27/06/2022 | n/a |                   |
| IA/0038/G | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or novel excipient | 07/06/2022 | n/a | manufacturer of a |
| IB/0037   | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                     | 25/05/2022 | n/a |                   |
| IA/0036/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                             | 14/03/2022 | n/a |                   |

<div style=\"page-break-after: always\"></div>

|             | change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                          |            |            |                 | A.5.b - Administrative   |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|--------------------------|
| IB/0035     | B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits                                                                                                                                                                                                                                                                                                                                          | 31/01/2022 | n/a        |                 |                          |
| IAIN/0034/G | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site | 10/01/2022 | 15/02/2023 | Annex II and PL |                          |
| IB/0032     | B.II.z - Quality change - Finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                    | 06/01/2022 | n/a        |                 |                          |

<div style=\"page-break-after: always\"></div>

| IA/0033   | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 07/12/2021   | n/a        |                        |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| T/0031    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 11/09/2021   | 19/10/2021 | SmPC, Labelling and PL |
| IB/0027/G | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other | 07/04/2021   | n/a        |                        |

<div style=\"page-break-after: always\"></div>

|                    | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                                           |            |     |                                   |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IB/0028/G          | This was an application for a group of variations. B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation | 26/03/2021 | n/a |                                   |
| IA/0029            | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 09/03/2021 | n/a |                                   |
| IB/0026            | B.IV.1.z - Change of a measuring or administration device - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 21/12/2020 | n/a |                                   |
| PSUSA/1751/ 202004 | Periodic Safety Update EU Single assessment - insulin glargine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 26/11/2020 | n/a | PRAC Recommendation - maintenance |
| IA/0025            | B.II.d.2.a - Change in test procedure for the finished                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 23/10/2020 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|           | product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                           |            |            |                                  |                         |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------------------------|
| IB/0024   | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                | 09/10/2020 | n/a        |                                  |                         |
| IB/0023   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                  | 07/10/2020 | 22/03/2021 | SmPC and PL                      |                         |
| IB/0021/G | This was an application for a group of variations. B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol B.II.f.1.d - Stability of FP - Change in storage conditions of the finished product or the diluted/reconstituted product | 01/04/2020 | 22/03/2021 | SmPC, Annex II, Labelling and PL |                         |
| IB/0020   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                            | 19/03/2020 | n/a        |                                  |                         |
| IA/0019/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or excipient                                                                                         | 27/02/2020 | n/a        |                                  | manufacturer of a novel |

<div style=\"page-break-after: always\"></div>

|                    | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                              |            |            |             |                                                                                                                                           |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/1751/ 201904 | Periodic Safety Update EU Single assessment - insulin glargine                                                                                                                                                                                                                                                                                                                                                                                             | 14/11/2019 | 16/01/2020 | SmPC and PL | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/1751/201904. |
| II/0009            | B.II.b.1.d - Replacement or addition of a manufacturing site for the FP - Site which requires an initial or product specific inspection                                                                                                                                                                                                                                                                                                                    | 26/09/2019 | n/a        |             |                                                                                                                                           |
| IB/0018            | B.II.f.1.a.1 - Stability of FP - Reduction of the shelf life of the finished product - As packaged for sale                                                                                                                                                                                                                                                                                                                                                | 16/08/2019 | 16/01/2020 | SmPC        |                                                                                                                                           |
| IAIN/0015/G        | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 17/05/2019 | n/a        |             |                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

| IB/0016   | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                   | 16/05/2019   | n/a        |                                  |                       |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-----------------------|
| IB/0014   | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                             | 03/05/2019   | n/a        |                                  |                       |
| IB/0013/G | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch place | 08/03/2019   | n/a        |                                  | control/testing takes |
| IAIN/0012 | B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes                                                                                                                                                                                 | 29/01/2019   | 17/04/2019 | SmPC, Labelling and PL           |                       |
| IB/0011   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                     | 18/12/2018   | 17/04/2019 | SmPC, Annex II, Labelling and PL |                       |
| IB/0010   | B.IV.1.z - Change of a measuring or administration device - Other variation                                                                                                                                                                                                                                                                                                        | 13/11/2018   | n/a        |                                  |                       |

<div style=\"page-break-after: always\"></div>

| PSUSA/1751/ 201804   | Periodic Safety Update EU Single assessment - insulin glargine                                                                                                                                                                                                                                                                                 | 31/10/2018   | n/a   | PRAC Recommendation - maintenance   |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-------------------------------------|
| IB/0008/G            | This was an application for a group of variations. B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                             | 23/08/2018   | n/a   |                                     |
| IB/0007/G            | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place               | 07/08/2018   | n/a   |                                     |
| IB/0006/G            | This was an application for a group of variations. B.I.a.4.a - Change to in-process tests or limits applied during the manufacture of the AS - Tightening of in-process limits B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.d.1.z - Stability of AS - Change in the re-test | 26/07/2018   | n/a   |                                     |

<div style=\"page-break-after: always\"></div>

|           | period or storage conditions - Other                                                                                                                                                                                                                                                                                                                                         |            |            |                        | period/storage variation   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------|
| IB/0004/G | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch | 24/07/2018 | n/a        |                        | control/testing takes      |
| IB/0003   | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                       | 21/06/2018 | n/a        |                        |                            |
| IB/0002   | B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol                                                                                                                                                                                          | 23/05/2018 | 17/04/2019 | SmPC                   |                            |
| IB/0001   | B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes                                                                                                                                                                          | 16/05/2018 | 17/04/2019 | SmPC, Labelling and PL |                            |